BioLife Solutions, Inc.

NasdaqCM:BLFS

Market Cap

USD 1.07 B

Share Price

USD 22.33

Avg Daily Volume

604,801

Change (1 day)

-0.98%

Change (1 year)

16.36%

Change (YTD)

-13.98%

BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -25.13%

BioLife Solutions, Inc. EBIT Margin is -25.13% for the Trailing 12 Months (TTM) ending September 30, 2024, a -39.21% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -41.34%, a -42.66% change year over year.
  • BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -72.11%, a 157.35% change year over year.
  • BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -28.02%, a -17.13% change year over year.
  • BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -33.81%, a -538.73% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin